Literature DB >> 6221843

Defect of T helper lymphocytes, as identified by the 5/9 monoclonal antibody, in patients with common variable hypogammaglobulinaemia.

F Pandolfi, G Corte, I Quinti, M Fiorilli, A Frieligsdorf, A Bargellesi, F Aiuti.   

Abstract

Peripheral blood lymphocytes from 17 patients with common variable hypogammaglobulinaemia (CVH) were tested for reactivity with the 5/9 monoclonal antibody which reacts with about 15% of normal T-PBL in which all helper activity is found. In PBL from CVH patients, the proportions of OKT4 and OKT8 positive cells were also determined. Five patients had normal percentages of 5/9 cells and a normal OKT4/OKT8 ratio. Twelve patients had significantly decreased (or absent) 5/9 lymphocytes. Among these, five had decreased 5/9 cells and a normal OKT4/OKT8 ratio and seven had decreased 5/9 cells and an inversion of the OKT4/OKT8 ratio. The deficiency of the helper phenotype T cell subpopulation identified by the 5/9 monoclonal antibody in many patients with CVH may be relevant in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6221843      PMCID: PMC1536803     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  Role of helper, suppressor and B-cell defects in the pathogenesis of the hypogammaglobulinemias.

Authors:  F P Siegal; M Siegal; R A Good
Journal:  N Engl J Med       Date:  1978-07-27       Impact factor: 91.245

2.  Subpopulations of human T lymphocytes. V. T lymphocytes with receptors for immunoglobulin M or G in patients with primary immunodeficiency disorders.

Authors:  S Gupta; R A Good
Journal:  Clin Immunol Immunopathol       Date:  1978-11

3.  Regulation of B cell differentiation by T cell subsets defined with monoclonal OKT4 and OKT8 antibodies in human cord blood.

Authors:  A Yachie; T Miyawaki; T Nagaoki; T Yokoi; M Mukai; N Uwadana; N Taniguchi
Journal:  J Immunol       Date:  1981-10       Impact factor: 5.422

4.  A monoclonal antibody reactive with human peripheral blood monocytes.

Authors:  J Breard; E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

5.  Abnormalities of regulatory T-cell subpopulations in patients with primary immunoglobulin deficiencies.

Authors:  F Pandolfi; I Quinti; A Frielingsdorf; G Goldstein; L Businco; F Aiuti
Journal:  Clin Immunol Immunopathol       Date:  1982-03

6.  Imbalances of T cell subpopulations in primary immunodeficiencies and systemic lupus erythematosus.

Authors:  F Pandolfi; I Quinti; M C Sirianni; M Fiorilli; S Zolla; F Aiuti
Journal:  Int Arch Allergy Appl Immunol       Date:  1981

7.  Abnormalities of T cell maturation and regulation in human beings with immunodeficiency disorders.

Authors:  E L Reinherz; M D Cooper; S F Schlossman; F S Rosen
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

8.  Characterization of a monoclonal antibody that defines an immunoregulatory T cell subset for immunoglobulin synthesis in humans.

Authors:  B F Haynes; D L Mann; M E Hemler; J A Schroer; J H Shelhamer; G S Eisenbarth; J L Strominger; C A Thomas; H S Mostowski; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

9.  Human T cell subpopulations defined by a monoclonal antibody. I. A small subset is responsible for proliferation to allogeneic cells or to soluble antigens and for helper activity for B cell differentiation.

Authors:  G Corte; M C Mingari; A Moretta; G Damiani; L Moretta; A Bargellesi
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

10.  Functional analysis of human T cell subsets defined by monoclonal antibodies. IV. Induction of suppressor cells within the OKT4+ population.

Authors:  Y Thomas; L Rogozinski; O H Irigoyen; S M Friedman; P C Kung; G Goldstein; L Chess
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  7 in total

1.  Increased IL-6 gene expression and production in patients with common variable immunodeficiency.

Authors:  F Pandolfi; R Paganelli; A Oliva; I Quinti; V Polidori; E Fanales-Belasio; E Guerra; F Aiuti
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

2.  T cell heterogeneity in patients with common variable immunodeficiency as assessed by abnormalities of T cell subpopulations and T cell receptor gene analysis.

Authors:  F Pandolfi; L Trentin; J E San Martin; J T Wong; J T Kurnick; R A Moscicki
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

Review 3.  Cellular mediators of inflammation: tregs and TH17 cells in gastrointestinal diseases.

Authors:  Franco Pandolfi; Rossella Cianci; Danilo Pagliari; Raffaele Landolfi; Giovanni Cammarota
Journal:  Mediators Inflamm       Date:  2010-02-08       Impact factor: 4.711

4.  CD4 lymphocyte subset abnormalities associated with impaired delayed cutaneous hypersensitivity reactions in patients with X-linked agammaglobulinaemia.

Authors:  A D Crockard; N A Boyd; T A McNeill; D R McCluskey
Journal:  Clin Exp Immunol       Date:  1992-04       Impact factor: 4.330

5.  Assessment of thymic output in common variable immunodeficiency patients by evaluation of T cell receptor excision circles.

Authors:  V Guazzi; F Aiuti; I Mezzaroma; F Mazzetta; G Andolfi; A Mortellaro; M Pierdominici; R Fantini; M Marziali; A Aiuti
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

Review 6.  The immune response to tumors as a tool toward immunotherapy.

Authors:  F Pandolfi; R Cianci; D Pagliari; F Casciano; C Bagalà; A Astone; R Landolfi; C Barone
Journal:  Clin Dev Immunol       Date:  2011-12-05

7.  Tissue-infiltrating lymphocytes analysis reveals large modifications of the duodenal "immunological niche" in coeliac disease after gluten-free diet.

Authors:  Rossella Cianci; Giovanni Cammarota; Giovanni Frisullo; Danilo Pagliari; Gianluca Ianiro; Maurizio Martini; Simona Frosali; Domenico Plantone; Valentina Damato; Fabio Casciano; Raffaele Landolfi; Anna Paola Batocchi; Franco Pandolfi
Journal:  Clin Transl Gastroenterol       Date:  2012-12-13       Impact factor: 4.488

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.